Literature DB >> 9479582

Mouse mammary tumor virus and its interaction with the immune system.

S R Ross1.   

Abstract

Mouse mammary tumor virus (MMTV) is a retrovirus that is transmitted through milk to offspring. Gut-associated B cells are the first cells to be infected during virus transmission, and these cells present a virus-encoded superantigen to cognate T cells. This allows MMTV to replicate and amplify in activated lymphocytes and ultimately results in virus transmission to the mammary epithelial cells. Because the superantigen has profound effects on the T cell repertoire and because MMTV replicates in lymphoid cells, loss of immune response to the virus may also play a role in its ability to persist within its host. Transcriptional control of MMTV expression also plays an important part in this pathway and DNA recognition sequences for transcription factors that allow its expression in lymphoid organs and mammary epithelia are encoded within the virus. Thus, this virus has evolved to take maximum advantage of its host's biology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9479582     DOI: 10.1007/BF02786445

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  35 in total

1.  Both T and B cells shed infectious mouse mammary tumor virus.

Authors:  J L Dzuris; T V Golovkina; S R Ross
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Structural relationships between the RNA of mammary tumor virus and those of other RNA tumor viruses.

Authors:  P H Duesberg; R D Cardiff
Journal:  Virology       Date:  1968-12       Impact factor: 3.616

3.  Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission.

Authors:  W Held; G A Waanders; A N Shakhov; L Scarpellino; H Acha-Orbea; H R MacDonald
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

4.  Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.

Authors:  J N Ihle; L O Arthur; D L Fine
Journal:  Cancer Res       Date:  1976-08       Impact factor: 12.701

5.  Virus envelope-based peptide vaccines against virus-induced mammary tumors.

Authors:  A S Dion; J J Knittel; S T Morneweck
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

6.  Lipopolysaccharide and dexamethasone induce mouse mammary tumor proviral gene expression and differentiation in B lymphocytes through distinct regulatory pathways.

Authors:  L B King; R B Corley
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

Review 7.  Mouse mammary tumor virus associated antigens and superantigens--immuno-molecular correlates of neoplastic progression.

Authors:  W Z Wei; R F Gill; H Wang
Journal:  Semin Cancer Biol       Date:  1993-06       Impact factor: 15.707

8.  Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses.

Authors:  T V Golovkina; I Piazzon; I Nepomnaschy; V Buggiano; M de Olano Vela; S R Ross
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  Endogenous mouse mammary tumor virus is expressed in several organs in addition to the lactating mammary gland.

Authors:  D Henrard; S R Ross
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation.

Authors:  Z Yao; E Maraskovsky; M K Spriggs; J I Cohen; R J Armitage; M R Alderson
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

View more
  5 in total

1.  CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription.

Authors:  Quan Zhu; Jaquelin P Dudley
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 2.  MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer.

Authors:  Pankaj Taneja; Donna P Frazier; Robert D Kendig; Dejan Maglic; Takayuki Sugiyama; Fumitake Kai; Neetu K Taneja; Kazushi Inoue
Journal:  Expert Rev Mol Diagn       Date:  2009-07       Impact factor: 5.225

Review 3.  Superantigens in human disease.

Authors:  A Bernal; T Proft; J D Fraser; D N Posnett
Journal:  J Clin Immunol       Date:  1999-05       Impact factor: 8.542

4.  The U3 and Env Proteins of Jaagsiekte Sheep Retrovirus and Enzootic Nasal Tumor Virus Both Contribute to Tissue Tropism.

Authors:  María C Rosales Gerpe; Laura P van Lieshout; Jakob M Domm; Joelle C Ingrao; Jodre Datu; Scott R Walsh; Darrick L Yu; Jondavid de Jong; Peter J Krell; Sarah K Wootton
Journal:  Viruses       Date:  2019-11-14       Impact factor: 5.048

Review 5.  Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis.

Authors:  Hussain Syed; Tara Penner; Andrew L Mason
Journal:  Viruses       Date:  2022-08-31       Impact factor: 5.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.